Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 35: 37-42, 1989;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Myrick, J. E.
Right arrow Articles by Hannon, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Myrick, J. E.
Right arrow Articles by Hannon, W. H.

Clinical Chemistry, Vol 35, 37-42, Copyright © 1989 by American Association for Clinical Chemistry

An improved radioimmunoassay of C-peptide and its application in a multiyear study

JE Myrick, EW Gunter, VL Maggio, DT Miller and WH Hannon
Centers for Disease Control, Division of Environmental Health Laboratory Sciences, Atlanta, GA 30333.

A commercial radioimmunoassay (RIA) for human proinsulin C-peptide was modified to improve its ruggedness and specificity, to decrease the influence of specimen matrix, and to shorten "hands-on" time. In the new protocol, we prepare calibrators in a C-peptide-free serum pool, prepared by treatment with activated charcoal (biological matrix), instead of in a defined matrix. This yielded essentially 100% analytical recoveries for C-peptide concentrations up to 300 pmol/L, a broader analytical range. We also corrected calibrators and unknown samples for nonspecific binding (NSB). Decreasing the concentration of ethanol (from 950 to 880 mL/L) for differential precipitation of the antigen-antibody complex resulted in an NSB of less than 10%, while maintaining high bound/total count percentages for samples and calibrators. C-peptide is thermally unstable without aprotinin at -20 degrees C and with or without aprotinin at 4 degrees C or above, but multiple freeze-thaw cycles do not affect C-peptide in serum. The modified C-peptide assay was applied to plasma from a multiyear study (fasting and post-carbohydrate-challenge subjects). During the four years of the study CVs ranged from 1.9% to 8.6% for replicate analyses of C-peptide in samples with concentrations less than or equal to 500 pmol/L. Between-run CVs were 3.8% to 8.2%, total CVs 3.8% to 10.7%.


The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
T. J. McDonald, B. A. Knight, B. M. Shields, P. Bowman, M. B. Salzmann, and A. T. Hattersley
Stability and Reproducibility of a Single-Sample Urinary C-Peptide/Creatinine Ratio and Its Correlation with 24-h Urinary C-Peptide
Clin. Chem., November 1, 2009; 55(11): 2035 - 2039.
[Abstract] [Full Text] [PDF]

Home page
 J Biomol ScreenHome page
F. Poulsen and K. B. Jensen
A Luminescent Oxygen Channeling Immunoassay for the Determination of Insulin in Human Plasma
J Biomol Screen, March 1, 2007; 12(2): 240 - 247.
[Abstract] [PDF]

Home page
 Clin. Chem.Home page
H. Hosoda, K. Doi, N. Nagaya, H. Okumura, E. Nakagawa, M. Enomoto, F. Ono, and K. Kangawa
Optimum Collection and Storage Conditions for Ghrelin Measurements: Octanoyl Modification of Ghrelin Is Rapidly Hydrolyzed to Desacyl Ghrelin in Blood Samples
Clin. Chem., June 1, 2004; 50(6): 1077 - 1080.
[Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
J. W Anderson, L. D Allgood, J. Turner, P. R Oeltgen, and B. P Daggy
Effects of psyllium on glucose and serum lipid responses in men with type 2 diabetes and hypercholesterolemia
Am. J. Clinical Nutrition, October 1, 1999; 70(4): 466 - 473.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American Association for Clinical Chemistry.